RESUMEN
BACKGROUND: To assess the influence of diagnosis and referral provided by specialists in oral diagnosis on disease-free survival and overall survival of patients with oral cancer. METHODS: A cohort of 282 patients with oral cancer treated at a regional cancer hospital from 1998 to 2016 was analyzed retrospectively. The referral register of the patients was analyzed and assigned to two groups: (1) those referred by oral diagnosis specialists (n = 129), or (2) those referred by nonspecialized professionals (n = 153). The cancer treatment evolution was assessed from the patients' records, and the outcome was registered concerning cancer recurrence and death. Sociodemographic and clinicopathological variables were explored as predictors of disease-free survival and overall survival. RESULTS: Group 1 exhibited lower T stages and a reduced incidence of regional and distant metastases. Surgery was performed in 75.2% of cases in Group 1, while in Group 2, the rate was 60.8%. Advanced T stages and regional metastases reduced the feasibility of surgery. Higher TNM stages and tumor recurrence were associated with decreased disease-free survival, while surgical intervention was a protective factor. Higher TNM stage had a negative impact on the overall survival. CONCLUSION: Specialized oral diagnosis did not directly impact disease-free survival and overall survival and did not influence the indication of surgery in oral cancer; however, it was associated with the diagnosis of early tumors and better prognosis.
Asunto(s)
Neoplasias de la Boca , Derivación y Consulta , Humanos , Neoplasias de la Boca/patología , Neoplasias de la Boca/mortalidad , Neoplasias de la Boca/terapia , Estudios Retrospectivos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Tasa de Supervivencia , Estadificación de Neoplasias , Recurrencia Local de Neoplasia , Supervivencia sin Enfermedad , Adulto , Estudios de Cohortes , Anciano de 80 o más Años , Diagnóstico BucalRESUMEN
PURPOSE: To assess the effect of a mucoadhesive herbal medicine containing curcuminoids and a glycerinated extract of Bidens pilosa L. (FITOPROT) in association with photobiomodulation (PBM) therapy and a Preventive Oral Care Program (POCP) compared to PBM and POCP in the treatment of radiotherapy (RT)-induced oral mucositis (ROM) and in the quality of life of these patients. METHODS: A double-blind clinical trial was performed with head and neck cancer patients undergoing RT or chemoradiotherapy. Participants were randomized into two groups: Group 1 (n=27): PBM and POCP; and Group 2 (n=25): PBM, POCP and FITOPROT. The PBM protocol was daily irradiation, 660 nm, 25mW, 0.25 J/point from the first until the last day of RT. The FITOPROT was used as mouthwash twice a day. ROM was evaluated based on the scales of the World Health Organization and National Cancer Institute. The quality of life was evaluated using the University of Washington Questionnaire, OHIP-14 and Patient-Reported Oral Mucositis Symptom Scale. The MMAS-8 questionnaire was used to evaluated the adherence to POCP and FITOPROT. Data were collected at baseline, 7th, 14th, 21st, and 30th RT sessions. RESULTS: No statistical differences were found between the groups for the ROM evaluation. Both groups experienced worsening of the quality of life during the RT. No statistically significant differences between groups were observed for any of the instruments evaluated. CONCLUSION: The results suggest that PBM associated with FITOPROT and POCP control the severity of ROM and stabilize the QoL of patients with head and neck cancer. TRIAL REGISTRATION: Brazilian Registry of Clinical Trials (ReBEC-RBR-9vddmr; UTN code: U1111-1193-2066), registered in August 8th, 2017.
Asunto(s)
Bidens , Neoplasias de Cabeza y Cuello , Terapia por Luz de Baja Intensidad , Estomatitis , Humanos , Calidad de Vida , Curcuma , Estomatitis/tratamiento farmacológico , Estomatitis/etiología , Estomatitis/prevención & control , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/radioterapia , Extractos Vegetales/uso terapéutico , Terapia por Luz de Baja Intensidad/métodosRESUMEN
BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogenous subtype involving different patterns of behavior and clinical course, demanding a complex, individualized sequence of treatment. The knowledge and attitudes of the affiliated members of the Brazilian Society of Mastology regarding TNBC were evaluated and a consensus regarding management and treatment was reached. METHODS: Affiliates completed a survey involving 44 objective questions. In addition, a specialist meeting was held with 27 experts and 3 ad hoc consultants. The panelists completed the survey before and after brainstorming. Answers achieving 70% of agreement were considered consensual. The chi-square test was used to compare answers between panelists and affiliates and the Kappa coefficient to calculate agreement. RESULTS: Consensus among the panelists increased from 26 (59.1%) to 32 questions (72.7%) following brainstorming (p = 0.17), including 7/10 questions on systemic treatment. Among the affiliates, consensus was achieved for 24 questions (54.5%), resulting in moderate agreement (κ = 0.445). Neoadjuvant chemotherapy should be indicated for almost all cases (except cT1a-b N0) and should include platinum agents. When indicated, immunotherapy is part of the standard of care. The panel reaffirmed the concept of no ink on tumor as indicative of adequate margins and the possibility of sentinel lymph node biopsy for cN1 patients who become cN0 following neoadjuvant therapy. Controversies remain on combining immunotherapy with capecitabine/olaparib in pertinent cases. CONCLUSION: Expert consensus was achieved for > 70% of the questions, with moderate agreement between panelists and affiliates. Educational interventions on systemic breast cancer treatment affected decision-making in 60% of the questions.
Asunto(s)
Neoplasias de la Mama Triple Negativas , Humanos , Neoplasias de la Mama Triple Negativas/diagnóstico , Neoplasias de la Mama Triple Negativas/terapia , Brasil , Terapia Neoadyuvante , Inmunoterapia , CapecitabinaRESUMEN
BACKGROUND: Oral mucositis (OM) is the significant complication of radio/chemotherapy treatment. This study evaluated the safety and efficacy of a mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L. (FITOPROT) in the prevention/treatment of OM. METHODS: Sixty-two patients were randomized into the group's intervention and placebo. Adverse effect assessment, OM grading, pain, and saliva collection were carried at the 1st, 15th, 21st, and final of radiotherapy (RT). Inflammatory salivary mediators were measured. RESULTS: FITOPROT decreased the severity of OM from the 15th to the final RT, while the placebo showed an increase in the severity (p < 0.05). Intervention group had a lower number of patients with ulcerated OM at the final RT (p < 0.05). Phytomedication prevented increases of IL-8 levels and reduced the salivary nitrite during RT. CONCLUSIONS: FITOPROT does not promote adverse effects, it appears to be effective at reducing the severity of OM, and it controls the concentration of pro-inflammatory mediators.
Asunto(s)
Bidens , Neoplasias de Cabeza y Cuello , Estomatitis , Quimioradioterapia , Diarilheptanoides/uso terapéutico , Método Doble Ciego , Humanos , Estomatitis/etiología , Estomatitis/prevención & controlRESUMEN
To assess the effectiveness of photobiomodulation therapy (PBMT) in the oral health-related quality of life (OHRQoL) of patients with head and neck cancer undergoing radiotherapy (RT), using the Oral Health Impact Profile-14 (OHIP-14) and the Patient-Reported Oral Mucositis (OM) Symptoms Scale (PROMS), and to correlate OM degree with the PROMS and OHIP-14 scores. Forty-eight patients undergoing RT for head and neck cancer were randomly assigned into two groups: PBMT group (n = 25)-daily PBMT associated with a preventive oral care program (POCP); and control group (n = 23)-receiving POCP exclusively. OHRQoL was assessed using the PROMS and OHIP-14 questionnaires. OM degrees were classified according to the World Health Organization and the National Cancer Institute scales. Assessments were performed at the 1st, 7th, 14th, 21st, and 30th RT sessions. PBMT was effective in preventing and treating severe OM. Both groups showed increased OHRQoL impacts throughout the RT sessions; however, higher impacts were observed in the control group, mainly at the final stage of treatment (21st and 30th RT sessions). Significant correlations were found between the severity of OM and PROMS scores in the total sample and the control group at all RT periods. PROMS and OM scores were positive correlated at 14th, 21st, and 30th RT sessions in the control group, suggesting that this instrument is useful in classifying OM. PBMT was effective in treating and preventing severe OM and OM-related symptoms, and with consequent positive impacts in OHRQoL in head and neck patients undergoing RT. The PROMS scale was helpful instrument for assessment of the severity of OM. Brazilian Clinical Trials database (ReBEC - RBR-5h4y4n), registered in Aug, 24th 2017.
Asunto(s)
Neoplasias de Cabeza y Cuello/complicaciones , Neoplasias de Cabeza y Cuello/radioterapia , Terapia por Luz de Baja Intensidad , Estomatitis/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida , Estomatitis/etiología , Estomatitis/radioterapia , Encuestas y CuestionariosRESUMEN
OBJECTIVE: To evaluate the occurrence and severity of oral complications, number of radiotherapy (RT) interruptions and quality of life (QoL) in a population of head and neck cancer patients receiving a preventive oral care program (POCP) and photobiomodulation therapy (PBMT). METHODS: Prospective cohort of 61 head and neck cancer patients undergoing radiochemotherapy were monitored and submitted to a POCP that included oral hygiene and plaque control, removal of infection foci, dental restorations, periodontal therapy, fluorotherapy, oral hydration, and denture removal at night, combined with daily PBMT. Outcomes included occurrence of adverse effects such as severity of oral mucositis (OM) and oral symptoms (pain, solid and fluid dysphagia, odynophagia, dysgeusia), quality of life impacts, and interruptions of radiotherapy (RT) due to symptoms. Disease-free and overall survival rates were evaluated. RESULTS: There was a significant improvement in oral health conditions between initial assessment and the two longitudinal assessments (p < 0.05), which indicates that the POCP was effective for plaque control and reduction of gingival inflammation. All participants were free of OM at the beginning of the RT regimen and only 45.9% after the 7th session, and few patients ranked the highest score of OM. For all symptoms related to OM, there was a progressive increase of severity until the 14th RT session, which remained stable until the completion of the RT regimen. The same effect was observed for the quality of life measures. Discontinued RT due to OM occurred in only three patients (5%), and the maximum duration was 10 days. The overall survival rate was 77% and disease-free survival was 73.8%. Lower survival time was observed for patients with no response to RT (p < 0.01). CONCLUSIONS: The findings of this study suggest a positive effect of an oral preventive care program for head and neck cancer patients submitted to RT. The PBMT associated with a rigorous POCP resulted in satisfactory control of oral adverse effects, reduction of quality of life impacts, and interruption of RT regimen due to severe OM.
Asunto(s)
Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Enfermedades de la Boca/etiología , Enfermedades de la Boca/prevención & control , Adulto , Anciano , Quimioradioterapia/efectos adversos , Quimioradioterapia/métodos , Estudios de Cohortes , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Enfermedades de la Boca/inducido químicamente , Salud Bucal , Higiene Bucal/métodos , Estudios Prospectivos , Calidad de Vida , Traumatismos por Radiación/etiología , Traumatismos por Radiación/prevención & controlRESUMEN
BACKGROUND: Oral mucositis (OM) is the most frequent and debilitating acute side effect associated with head and neck cancer (HNC) treatment. When present, severe OM negatively impacts the quality of life of patients undergoing HNC treatment. Photobiomodulation is a well-consolidated and effective therapy for the treatment and prevention of severe OM, and is associated with a cost reduction of the cancer treatment. Although an increase in the quality of life and a reduction in the severity of OM are well described, there is no study on cost-effectiveness for this approach considering the quality of life as a primary outcome. In addition, little is known about the photobiomodulation effects on salivary inflammatory mediators. Thus, this study aimed to assess the cost-effectiveness of the photobiomodulation therapy for the prevention and control of severe OM and its influence on the salivary inflammatory mediators. METHODS/DESIGN: This randomized, double-blind clinical trial will include 50 HNC patients undergoing radiotherapy or chemoradiotherapy. The participants will be randomized into two groups: intervention group (photobiomodulation) and control group (preventive oral care protocol). OM (clinical assessment), saliva (assessment of collected samples) and quality of life (Oral Health Impact Profile-14 and Patient-Reported Oral Mucositis Symptoms questionnaires) will be assessed at the 1st, 7th, 14th, 21st and 30th radiotherapy sessions. Oxidative stress and inflammatory cytokine levels will be measured in the saliva samples of all participants. The costs are identified, measured and evaluated considering the radiotherapy time interval. The incremental cost-effectiveness ratio will be estimated. The study will be conducted according to the Brazilian public health system perspective. DISCUSSION: Photobiomodulation is an effective therapy that reduces the cost associated with OM treatment. However, little is known about its cost-effectiveness, mainly when quality of life is the effectiveness measure. Additionally, this therapy is not supported by the Brazilian public health system. Therefore, this study widens the knowledge about the safety of and strengthens evidence for the use of photobiomodulation therapy, providing information for public policy-makers and also for dental care professionals. This study is strongly encouraged due to its clinical relevance and the possibility of incorporating new technology into public health systems. TRIAL REGISTRATION: Brazilian Registry of Clinical Trials-ReBEC, RBR-5h4y4n . Registered on 13 June 2017.
Asunto(s)
Quimioradioterapia/efectos adversos , Irradiación Craneana/efectos adversos , Neoplasias de Cabeza y Cuello/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Traumatismos por Radiación/prevención & control , Glándulas Salivales/efectos de la radiación , Estomatitis/prevención & control , Biomarcadores/metabolismo , Brasil , Quimioradioterapia/economía , Análisis Costo-Beneficio , Irradiación Craneana/economía , Citocinas/metabolismo , Método Doble Ciego , Neoplasias de Cabeza y Cuello/economía , Costos de la Atención en Salud , Humanos , Mediadores de Inflamación/metabolismo , Terapia por Luz de Baja Intensidad/efectos adversos , Terapia por Luz de Baja Intensidad/economía , Estrés Oxidativo , Traumatismos por Radiación/economía , Traumatismos por Radiación/etiología , Traumatismos por Radiación/metabolismo , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Riesgo , Saliva/metabolismo , Glándulas Salivales/metabolismo , Índice de Severidad de la Enfermedad , Estomatitis/economía , Estomatitis/etiología , Estomatitis/metabolismo , Factores de Tiempo , Resultado del TratamientoRESUMEN
SUMMARY This recommendation consensus for hypofractionated whole-breast radiotherapy (RT) was organized by the Brazilian Society of Radiotherapy (SBRT) considering the optimal scenario for indication and safety in the technology applied. All controversies and contraindication matters (hypofractionated RT in patients who underwent chemotherapy [CT], hypofractionated RT in lymphatic drainage, hypofractionated RT after mastectomy with or without immediate reconstruction, boost during surgery, hypofractionated RT in patients under 50 years old, hypofractionated RT in large breasts, hypofractionated RT in histology of carcinoma in situ [DCIS]) was discussed during a meeting in person, and a consensus was reached when there was an agreement of at least 75% among panel members. The grade for recommendation was also suggested according to the level of scientific evidence available, qualified as weak, medium, or strong. Thus, this consensus will aid Brazilian radiotherapy experts regarding indications and particularities of this technique as a viable and safe alternative for the national reality.
RESUMO Este consenso de recomendações para a radioterapia (RT) hipofracionada de toda a mama foi organizado pela Sociedade Brasileira de Radioterapia (SBRT) considerando o cenário ideal para indicação e segurança na tecnologia aplicada. Questões de controvérsias e contraindicações (RT hipofracionada em pacientes submetidas à quimioterapia [QT], RT hipofracionada nas drenagens linfáticas, RT hipofracionada após mastectomia com ou sem reconstrução imediata, a realização de reforço de dose em leito cirúrgico [ou boost], RT hipofracionada em pacientes com idade menor que 50 anos, RT hipofracionada em mamas volumosas, RT hipofracionada em histologia de carcinoma in situ [CDIS]) foram discutidas em encontro presencial, sendo o consenso atingido quando existisse concordância de pelo menos 75% dos panelistas. O grau de recomendação foi também sugerido de acordo com o nível de evidência científico disponível, qualificado entre fraco, médio ou forte. Assim, este consenso deverá servir para auxiliar os especialistas da radioterapia brasileira em relação às indicações e particularidades dessa técnica, como uma alternativa segura e viável para a realidade nacional.
Asunto(s)
Humanos , Femenino , Neoplasias de la Mama/radioterapia , Carcinoma/radioterapia , Hipofraccionamiento de la Dosis de Radiación/normas , Brasil , Mama/efectos de la radiación , Neoplasias de la Mama/patología , Carcinoma/patología , Factores de Riesgo , Medicina Basada en la EvidenciaRESUMEN
PURPOSE: To investigate the influence of music therapy on the reduction of fatigue in women with breast or gynecological malignant neoplasia during radiotherapy, since it is one of the most frequent side effects of this type of treatment, and may interfere with self-esteem, social activities, and quality of life. EXPERIMENTAL DESIGN: Randomized controlled trial (control group [CG] and music therapy group [MTG]) to assess fatigue, quality of life, and symptoms of depression in women undergoing radiotherapy using the Functional Assessment of Cancer Therapy: Fatigue (FACT-F) version 4, Functional Assessment of Cancer Therapy-General (FACT-G) version 4, and Beck Depression Inventory in 3 separate times, namely, during the first week of radiotherapy, on the week of the intermediary phase, and during the last week of radiotherapy. Individual 30- to 40-minute sessions of music therapy with the presence of a trained music therapist were offered to participants. RESULTS: In this study, 164 women were randomized and 116 (63 CG and 53 MTG) were included in the analyses, with mean age of 52.90 years (CG) and 51.85 years (MTG). Participants in the MTG had an average of 10 music therapy sessions, totaling 509 sessions throughout the study. FACT-F results were significant regarding Trial Outcome Index ( P = .011), FACT-G ( P = .005), and FACT-F ( P = .001) for the MTG compared with the CG. CONCLUSIONS: Individual music therapy sessions may be effective to reduce fatigue related to cancer and symptoms of depression, as well as to improve quality of life for women with breast or gynecological cancer undergoing radiotherapy. Further well-designed research studies are needed to adequately determine the effects of music therapy on fatigue.
Asunto(s)
Neoplasias de la Mama/radioterapia , Fatiga/etiología , Fatiga/terapia , Neoplasias de los Genitales Femeninos/radioterapia , Musicoterapia/métodos , Radioterapia/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
This recommendation consensus for hypofractionated whole-breast radiotherapy (RT) was organized by the Brazilian Society of Radiotherapy (SBRT) considering the optimal scenario for indication and safety in the technology applied. All controversies and contraindication matters (hypofractionated RT in patients who underwent chemotherapy [CT], hypofractionated RT in lymphatic drainage, hypofractionated RT after mastectomy with or without immediate reconstruction, boost during surgery, hypofractionated RT in patients under 50 years old, hypofractionated RT in large breasts, hypofractionated RT in histology of carcinoma in situ [DCIS]) was discussed during a meeting in person, and a consensus was reached when there was an agreement of at least 75% among panel members. The grade for recommendation was also suggested according to the level of scientific evidence available, qualified as weak, medium, or strong. Thus, this consensus will aid Brazilian radiotherapy experts regarding indications and particularities of this technique as a viable and safe alternative for the national reality.
Asunto(s)
Neoplasias de la Mama/radioterapia , Carcinoma/radioterapia , Hipofraccionamiento de la Dosis de Radiación/normas , Brasil , Mama/efectos de la radiación , Neoplasias de la Mama/patología , Carcinoma/patología , Medicina Basada en la Evidencia , Femenino , Humanos , Factores de RiesgoRESUMEN
OBJECTIVE: to analyze the overall survival and prognostic factors of women with breast cancer in the city of Goiânia. METHODS: this is a retrospective, cross-sectional, observational study that included women with malignant neoplasms of the breast identified by the Goiânia Population-based Cancer Registry. The variables studied were age at diagnosis, tumor size, staging, axillary lymph node involvement, tumor grade, disease extent, hormone receptors, and c-erb-B2 oncoprotein. We performed overall survival analyzes of five and ten years. RESULTS: we included 2,273 patients in the study, with an overall survival of 72.1% in five years and 57.8% in ten years. In the multivariate analysis adjusted for tumor size, the factors that influenced the prognosis were axillary lymph nodes, histological grade, progesterone receptor, c erb B2, T staging and disease extension. CONCLUSION: overall survival in ten years is below that observed in other countries, and possibly reflects what happens with the majority of the Brazilian population. The prognostic factors found in this population follow the same international patterns.
Asunto(s)
Neoplasias de la Mama/mortalidad , Adulto , Brasil/epidemiología , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Tasa de Supervivencia , Factores de Tiempo , Salud UrbanaRESUMEN
ABSTRACT Objective: to analyze the overall survival and prognostic factors of women with breast cancer in the city of Goiânia. Methods: this is a retrospective, cross-sectional, observational study that included women with malignant neoplasms of the breast identified by the Goiânia Population-based Cancer Registry. The variables studied were age at diagnosis, tumor size, staging, axillary lymph node involvement, tumor grade, disease extent, hormone receptors, and c-erb-B2 oncoprotein. We performed overall survival analyzes of five and ten years. Results: we included 2,273 patients in the study, with an overall survival of 72.1% in five years and 57.8% in ten years. In the multivariate analysis adjusted for tumor size, the factors that influenced the prognosis were axillary lymph nodes, histological grade, progesterone receptor, c erb B2, T staging and disease extension. Conclusion: overall survival in ten years is below that observed in other countries, and possibly reflects what happens with the majority of the Brazilian population. The prognostic factors found in this population follow the same international patterns.
RESUMO Objetivo: analisar a sobrevida global e os fatores prognósticos de mulheres com câncer de mama na cidade de Goiânia. Métodos: estudo observacional, retrospectivo, transversal, que incluiu mulheres portadoras de neoplasias malignas da mama identificadas pelo Registro de Câncer de Base Populacional de Goiânia. As variáveis estudadas foram: idade ao diagnóstico, tamanho do tumor, estadiamento, comprometimento dos linfonodos axilares, grau tumoral, extensão da doença, receptores hormonais e oncoproteína c-erb-B2. Foram realizadas análises de sobrevida global, de cinco e de dez anos. Resultados: foram incluídas no estudo 2273 pacientes, com sobrevida global em cinco anos de 72,1% e de 57,8% em dez anos. Na análise multivariada ajustada pelo tamanho do tumor, os fatores que influenciaram o prognóstico foram: linfonodos axilares, grau histológico, receptor de progesterona, c-erb-B2, estadiamento T e extensão da doença. Conclusão: a sobrevida global em dez anos está abaixo da observada em outros países, e possivelmente reflete o que acontece com a maioria da população brasileira. Os fatores prognósticos encontrados nesta população seguem o mesmo padrão internacional.
Asunto(s)
Humanos , Femenino , Adulto , Neoplasias de la Mama/mortalidad , Pronóstico , Factores de Tiempo , Brasil/epidemiología , Salud Urbana , Estudios Transversales , Tasa de Supervivencia , Estudios Retrospectivos , Persona de Mediana EdadRESUMEN
OBJECTIVE: To describe the temporal trends in female breast cancer mortality rates in Brazil in its macro-regions and states between 1980 and 2009. METHODS: This was an ecological time-series study using data on breast cancer deaths registered in the Mortality Data System (SIM/WHO) and census data on the resident population collected by the Brazilian Institute of Geography and Statistics (IBGE/WHO). Joinpoint regression analyses were used to identify the significant changes in trends and to estimate the annual percentage change (APC) in mortality rates. RESULTS: Female breast cancer mortality rates in Brazil tended to stabilize from 1994 onward (APC = 0.4%). Considering the Brazilian macro-regions, the annual mortality rates decreased in the Southeast, stabilized in the South and increased in the Northeast, North, and Midwest. Only the states of Sao Paulo (APC = -1.9%), Rio Grande do Sul (APC = -0.8%) and Rio de Janeiro (APC = -0.6%) presented a significant decline in mortality rates. The greatest increases were found in Maranhao (APC=12%), Paraiba (APC=11.9%), and Piaui (APC=10.9%). CONCLUSION: Although there has been a trend toward stabilization in female breast cancer mortality rates in Brazil, when the mortality rate of each macro-region and state is analyzed individually, considerable inequalities are found, with rate decline or stabilization in states with higher socioeconomic levels and a substantial increase in those with lower socioeconomic levels.
Asunto(s)
Neoplasias de la Mama/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Femenino , Geografía Médica/estadística & datos numéricos , Disparidades en el Estado de Salud , Humanos , Incidencia , Factores Socioeconómicos , Adulto JovenRESUMEN
OBJECTIVE: To describe the temporal trends in female breast cancer mortality rates in Brazil in its macro-regions and states between 1980 and 2009. METHODS: This was an ecological time-series study using data on breast cancer deaths registered in the Mortality Data System (SIM/WHO) and census data on the resident population collected by the Brazilian Institute of Geography and Statistics (IBGE/WHO). Joinpoint regression analyses were used to identify the significant changes in trends and to estimate the annual percentage change (APC) in mortality rates. RESULTS: Female breast cancer mortality rates in Brazil tended to stabilize from 1994 onward (APC = 0.4%). Considering the Brazilian macro-regions, the annual mortality rates decreased in the Southeast, stabilized in the South and increased in the Northeast, North, and Midwest. Only the states of Sao Paulo (APC = -1.9%), Rio Grande do Sul (APC = -0.8%) and Rio de Janeiro (APC = -0.6%) presented a significant decline in mortality rates. The greatest increases were found in Maranhao (APC=12%), Paraiba (APC=11.9%), and Piaui (APC=10.9%). CONCLUSION: Although there has been a trend toward stabilization in female breast cancer mortality rates in Brazil, when the mortality rate of each macro-region and state is analyzed individually, considerable inequalities are found, with rate decline or stabilization in states with higher socioeconomic levels and a substantial increase in those with lower socioeconomic levels.
Asunto(s)
Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Adulto Joven , Neoplasias de la Mama/mortalidad , Brasil/epidemiología , Geografía Médica/estadística & datos numéricos , Disparidades en el Estado de Salud , Incidencia , Factores SocioeconómicosRESUMEN
CONTEXT AND OBJECTIVE: Studies have shown increased prevalence rates for breast cancer, relating to higher incidence, longer survival and breast cancer prevention programs among populations. The aim here was to analyze the annual prevalence of breast cancer in Goiânia over a 15-year period. DESIGN AND SETTING: This was a cross-sectional study on women with breast cancer diagnosed in Goiânia, Goiás, Brazil, from 1988 to 2002. METHODS: The breast cancer cases were identified in the database of the Population-Based Cancer Registry of Goiânia. The 15-year period was stratified into three five-year periods. The cases were followed up for five years, and the mortality database was used to exclude deaths. The population of the official census was used as the denominator for rate calculations. RESULTS: The coefficient of breast cancer prevalence in Goiania was 22.87/100,000 in 1988 and 220.22/100,000 women in 2002. The analyses for periods showed that in the first period, the rate was 19.39/100,000 and that it was 44.79/100,000 in the last period. For the fifteen years analyzed, the prevalence rate for breast cancer was 127.24/100,000 women. The annual percentage change was 27.07 (P < 0.001; 95% confidence interval, CI: 20.79-33.67) from 1988 to 1992 and 9.39 (P < 0.001; 95% CI: 8.52-10.25) from 1992 to 2002. CONCLUSION: There was an increase in the breast cancer prevalence rate in the city of Goiânia between 1988 and 2002, possibly relating to the improvement in the screening and treatment of breast cancer.
Asunto(s)
Neoplasias de la Mama/epidemiología , Brasil/epidemiología , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Prevalencia , Estudios Retrospectivos , Factores de TiempoRESUMEN
OBJECTIVE: To describe cases of breast cancer in women living in Goiânia from 1989-2003. METHODS: We conducted a retrospective, descriptive stud, which included all cases of breast cancer occurring in residents of Goiânia, identified by the Population-Based Cancer Registry of Goiânia (RCBPGO) in the period from 1989 to 2003. The variables were: age, method of diagnosis, topographic location, morphology and extent of breast cancer. We used frequencies and percentage rates, and Poisson regression to determine the annual percentage change (APC). RESULTS: We identified 3204 cases of breast cancer. The most frequent topographic location was the superior-lateral quadrant (53.7%). Infiltrating ductal carcinoma (IDC) was the most frequent, with 2582 cases (80.6%), followed by infiltrating lobular carcinoma (ILC), with 155 cases (4.8%). There was a significant increase of both the IDC and the ILC, with APCs of 11.0% and 15.4%, respectively. The ratio between IDC and ILC was not influenced by age (p = 0.98). As for tumor extent at diagnosis, 45.6% were located in the breast, and the APC was 16.1% (CI = 12.4 to 20.0, p <0.001). There was a trend of APC reduction of metastatic cases (-3.8, CI = -8.6 to 1.2, p = 0.12). CONCLUSION: The topographical location and histological type of breast cancer in the city of Goiania followed the pattern of other countries. The main morphological types were not influenced by age. There was a large increase in initial cases.
Asunto(s)
Neoplasias de la Mama/epidemiología , Adulto , Brasil/epidemiología , Neoplasias de la Mama/patología , Femenino , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Factores de TiempoRESUMEN
OBJETIVO: Descrever os casos de câncer de mama nas mulheres residentes em Goiânia no período 1989-2003. MÉTODOS: Estudo retrospectivo, descritivo, que incluiu todos os casos de câncer de mama ocorridos nas moradoras de Goiânia, identificados pelo Registro de Câncer de Base Populacional de Goiânia (RCBPGO), no período de 1989 a 2003. As variáveis estudadas foram: idade, método de diagnóstico, localização topográfica, morfologia e extensão do câncer de mama. Foram utilizadas frequências e taxas percentuais, além da regressão de Poisson para determinação da mudança percentual anual (MPA). RESULTADOS: Foram identificados 3204 casos de câncer de mama. A localização topográfica mais frequente foi o quadrante superior lateral (53,7 por cento). O carcinoma ductal infiltrante (CDI) foi o mais freqüente, com 2582 casos (80,6 por cento), seguido pelo carcinoma lobular infiltrante (CLI), com 155 casos (4,8 por cento). Houve aumento significante tanto do CDI quanto do CLI, sendo a MPA de 11,0 por cento e de 15,4 por cento, respectivamente. A proporção entre CDI e CLI não foi influenciada pela idade (p=0,98). Quanto à extensão do tumor ao diagnóstico, 45,6 por cento dos casos eram localizados na mama, sendo que a MPA foi de 16,1 por cento (IC= 12,4 a 20,0; p<0,001). Houve tendência de redução da MPA dos casos metastáticos (-3,8; IC= -8,6 a 1,2; p=0,12). CONCLUSÃO: A localização topográfica e o tipo histológico do câncer de mama, na cidade de Goiânia, seguem o padrão de outros países. Os principais tipos morfológicos não foram influenciados pela idade. Houve grande aumento de casos iniciais.
OBJECTIVE: To describe cases of breast cancer in women living in Goiânia from 1989-2003. METHODS: We conducted a retrospective, descriptive stud, which included all cases of breast cancer occurring in residents of Goiânia, identified by the Population-Based Cancer Registry of Goiânia (RCBPGO) in the period from 1989 to 2003. The variables were: age, method of diagnosis, topographic location, morphology and extent of breast cancer. We used frequencies and percentage rates, and Poisson regression to determine the annual percentage change (APC). RESULTS: We identified 3204 cases of breast cancer. The most frequent topographic location was the superior-lateral quadrant (53.7 percent). Infiltrating ductal carcinoma (IDC) was the most frequent, with 2582 cases (80.6 percent), followed by infiltrating lobular carcinoma (ILC), with 155 cases (4.8 percent). There was a significant increase of both the IDC and the ILC, with APCs of 11.0 percent and 15.4 percent, respectively. The ratio between IDC and ILC was not influenced by age (p = 0.98). As for tumor extent at diagnosis, 45.6 percent were located in the breast, and the APC was 16.1 percent (CI = 12.4 to 20.0, p <0.001). There was a trend of APC reduction of metastatic cases (-3.8, CI = -8.6 to 1.2, p = 0.12). CONCLUSION: The topographical location and histological type of breast cancer in the city of Goiania followed the pattern of other countries. The main morphological types were not influenced by age. There was a large increase in initial cases.
Asunto(s)
Adulto , Femenino , Humanos , Persona de Mediana Edad , Neoplasias de la Mama/epidemiología , Brasil/epidemiología , Neoplasias de la Mama/patología , Estudios Retrospectivos , Factores de TiempoRESUMEN
CONTEXT AND OBJECTIVE: Studies have shown increased prevalence rates for breast cancer, relating to higher incidence, longer survival and breast cancer prevention programs among populations. The aim here was to analyze the annual prevalence of breast cancer in Goiânia over a 15-year period. DESIGN AND SETTING: This was a cross-sectional study on women with breast cancer diagnosed in Goiânia, Goiás, Brazil, from 1988 to 2002. METHODS: The breast cancer cases were identified in the database of the Population-Based Cancer Registry of Goiânia. The 15-year period was stratified into three five-year periods. The cases were followed up for five years, and the mortality database was used to exclude deaths. The population of the official census was used as the denominator for rate calculations. RESULTS: The coefficient of breast cancer prevalence in Goiania was 22.87/100,000 in 1988 and 220.22/100,000 women in 2002. The analyses for periods showed that in the first period, the rate was 19.39/100,000 and that it was 44.79/100,000 in the last period. For the fifteen years analyzed, the prevalence rate for breast cancer was 127.24/100,000 women. The annual percentage change was 27.07 (P < 0.001; 95 percent confidence interval, CI: 20.79-33.67) from 1988 to 1992 and 9.39 (P < 0.001; 95 percent CI: 8.52-10.25) from 1992 to 2002. CONCLUSION: There was an increase in the breast cancer prevalence rate in the city of Goiânia between 1988 and 2002, possibly relating to the improvement in the screening and treatment of breast cancer.
CONTEXO E OBJETIVO: Estudos têm demonstrado um aumento da taxa de prevalência para o câncer de mama relacionado à maior incidência, maior sobrevida e programas de prevenção do câncer de mama na população. O objetivo foi analisar a prevalência anual de câncer de mama em Goiânia, num período de 15 anos. TIPO DE ESTUDO E LOCAL: Estudo de corte transversal de mulheres com câncer de mama em Goiânia, Goiás, Brasil, no período de 1988 a 2002. METODOS: Os casos de câncer de mama foram identificados na base de dados do Registro de Câncer de Base Populacional de Goiânia. Os 15 anos foram estratificados em quinquênios. As pacientes foram seguidas por cinco anos e utilizaram-se os dados da mortalidade para exclusão dos óbitos. Utilizou-se a população do censo oficial como denominador para o cálculo das taxas. RESULTADOS: O coeficiente de prevalência de câncer de mama em Goiânia foi de 22,87/100000 em 1988 e 220,22/100000 mulheres em 2002. As análises para os períodos evidenciaram que, no primeiro período, a taxa foi de 19,39/100000, e de 44,79/100000 no último período. Nos 15 anos de análise, a taxa de prevalência foi de 127,24/100000 mulheres. A mudança percentual anual foi de 27,07 (P < 0,001; intervalo de confiança, IC 95 por cento 20,79-33,67) de 1988 a 1992 e 9,39 (P < 0,001; IC 95 por cento 8,52-10,25) de 1992 a 2002. CONCLUSÃO: Houve aumento da taxa de prevalência do câncer de mama na cidade de Goiânia no período de 1988 a 2002, possivelmente relacionado à melhora do rastreamento e do tratamento do câncer de mama.
Asunto(s)
Femenino , Humanos , Neoplasias de la Mama/epidemiología , Brasil/epidemiología , Estudios Transversales , Estudios de Seguimiento , Incidencia , Prevalencia , Estudios Retrospectivos , Factores de TiempoRESUMEN
CONTEXT AND OBJECTIVE: It has been suggested that there has been a large increase in breast cancer incidence among young women over the last decade. The aim of this study was to describe the incidence of breast cancer among young women up to 39 years of age in Goiânia, between 1988 and 2003, and to compare this with other age groups. DESIGN AND SETTING: Retrospective study using the database of the Population-based Cancer Registry of Goiânia, State of Goiás, Brazil. METHODS: The incidence was calculated according to age groups: up to 39 years, 40 to 59 years and 60 years and over. Average annual percentage changes (AAPCs) were estimated for the different age groups using Poisson regression. RESULTS: Over this period, 3,310 new cases were recorded. The standardized incidence was 2.89/100,000 in 1988 and increased to 6.37/100,000 in 2003 (R(2) = 0.52) for the group aged up to 39 years (p < 0.003). For the group from 40 to 59 years old, the incidence was 14.39/100,000 in 1988 and 41.70/100,000 in 2003 (R(2) = 0.85; p < 0.001). For the group aged 60 years and over, it was 17.62/100,000 and 28.49/100,000, respectively (R(2) = 0.67; p < 0.001). The AAPCs were 5.22%, 5.53% and 4.54% for the age groups up to 39, 40 to 59 and 60 years and over, respectively. CONCLUSIONS: The incidence of breast cancer among young women in Goiânia has been increasing significantly, although this change was similar to the increase in other age groups.
Asunto(s)
Neoplasias de la Mama/epidemiología , Adulto , Distribución por Edad , Brasil/epidemiología , Femenino , Humanos , Incidencia , Persona de Mediana Edad , Estudios Retrospectivos , Adulto JovenRESUMEN
CONTEXT AND OBJECTIVE: It has been suggested that there has been a large increase in breast cancer incidence among young women over the last decade. The aim of this study was to describe the incidence of breast cancer among young women up to 39 years of age in Goiânia, between 1988 and 2003, and to compare this with other age groups. DESIGN AND SETTING: Retrospective study using the database of the Population-based Cancer Registry of Goiânia, State of Goiás, Brazil. METHODS: The incidence was calculated according to age groups: up to 39 years, 40 to 59 years and 60 years and over. Average annual percentage changes (AAPCs) were estimated for the different age groups using Poisson regression. RESULTS: Over this period, 3,310 new cases were recorded. The standardized incidence was 2.89/100,000 in 1988 and increased to 6.37/100,000 in 2003 (R² = 0.52) for the group aged up to 39 years (p < 0.003). For the group from 40 to 59 years old, the incidence was 14.39/100,000 in 1988 and 41.70/100,000 in 2003 (R² = 0.85; p < 0.001). For the group aged 60 years and over, it was 17.62/100,000 and 28.49/100,000, respectively (R² = 0.67; p < 0.001). The AAPCs were 5.22 percent, 5.53 percent and 4.54 percent for the age groups up to 39, 40 to 59 and 60 years and over, respectively. CONCLUSIONS: The incidence of breast cancer among young women in Goiânia has been increasing significantly, although this change was similar to the increase in other age groups.
CONTEXTO E OBJETIVO: Tem sido sugerido que há um grande aumento na incidência do câncer de mama em mulheres jovens na última década. O objetivo deste estudo é descrever a incidência do câncer de mama em mulheres jovens (até 39 anos) em Goiânia, entre 1988 e 2003, comparando com os demais grupos etários. DESENHO E LOCAL: Estudo retrospectivo utilizando o banco de dados do Registro de Câncer de Base populacional de Goiânia/Goiás, Brasil. MÉTODOS: As incidências foram calculadas de acordo com os grupos etários: até 39 anos, 40 a 59 anos e, 60 anos acima. A mudança da média percentual anual (MMPA) foi estimada para os diferentes grupos usando a regressão de Poisson. RESULTADOS: No período, foram registrados 3.310 novos casos. A incidência padronizada foi de 2,89/100.000 em 1988 tendo aumentado para 6,37/100.000 em 2003 (R² = 0,52) para o grupo com até 39 anos (p < 0,003). Para o grupo de 40 a 59 anos a incidência foi de 14,39/100.000 em 1988 e de 41,70/100.000 em 2003 (R² = 0,85; p < 0,001); para o grupo de 60 anos e acima foi de 17,62/100.000 e 28,49/100.000, respectivamente (R² = 0,67; p < 0,001). A MMPA foi de 5,22 por cento, 5,53 por cento e 4,54 por cento para os grupos etários de até 39 anos, 40 a 59 e 60 ou mais, respectivamente. CONCLUSÕES: A incidência de câncer de mama em mulheres jovens em Goiânia vem aumentando significativamente, entretanto esse aumento é semelhante ao observado nos demais grupos etários.